Global Respiratory Disease Vaccine Market Report By Disease Type (Chronic Obstructive Pulmonary Disease (COPD), Diphtheria, Measles, Pertussis, Pneumonia), By Vaccine (DTaP, Haemophilus Influenzae Type B (HIB), MMR, PPSV23, Respiratory Syncytial Virus (RSV) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

Name: Global Respiratory Disease Vaccine Market Report
Brand: Value Market Research
SKU: Pharmaceuticals
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11212585

April 2021

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

The global demand for Respiratory Disease Vaccine Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.

Respiratory diseases are the diseases that attack the respiratory system, including lungs and the other parts. The most common causes of respiratory diseases are bacterial and viral infections. Other reasons include air pollution and smoking. Respiratory diseases include pneumonia (bacterial, viral), influenza, chronic obstructive pulmonary disease (COPD), asthma, lung cancer, and pulmonary fibrosis. Vaccination is considered to be the safest way to fight infectious diseases. A single vaccine or combination of vaccines is supposed to be effective against such diseases.

Market Dynamics

The prime movers of the global market include the rising prevalence of respiratory disorders, increasing chronic obstructive pulmonary disease. Government organizations are supporting vaccine production as a step forward to prevent respiratory diseases. A large number of respiratory disease vaccines are in the pipeline, and undergoing clinical trials in the entire world. The key market players are investing in R & D to develop vaccines with enhanced efficacy. All the factors altogether are expected to boost the market. COVID-19 pandemic is a respiratory disease caused SARS-COV-2 virus. Currently, there is no antiviral drug or vaccine available in the world to cure the disease. A large number of pharmaceutical organizations across the globe are working strenuously to develop the vaccine at the earliest. The pandemic is expected to drive the global respiratory disease market at a fast pace owing to massive demand.

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of respiratory disease vaccine.

Market Segmentation

The entire respiratory disease vaccine market has been sub-categorized into disease type and vaccine. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Disease Type

Chronic Obstructive Pulmonary Disease (COPD)
Diphtheria
Measles
Pertussis
Pneumonia

By Vaccine

DTaP
Haemophilus Influenzae Type B (HIB)
MMR
PPSV23
Respiratory Syncytial Virus (RSV)

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for respiratory disease vaccine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Global Respiratory Disease Vaccine Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the respiratory disease vaccine market include GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Sanofi S.A., Serum Institute of India Private Limited. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Respiratory Disease Vaccine Market
       2.2. Global Respiratory Disease Vaccine Market Snapshot

3 . RESPIRATORY DISEASE VACCINE – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Respiratory Disease Vaccine Market
       3.3. Market Restraints of Respiratory Disease Vaccine Market
       3.4. Opportunities of Respiratory Disease Vaccine Market
       3.5. Trends of Respiratory Disease Vaccine Market
       3.6. Porter’s Five Force Analysis of Respiratory Disease Vaccine Market
       3.7. Respiratory Disease Vaccine Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Disease Type
           3.7.2 Market Attractive Analysis by Vaccine
           3.7.3 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Respiratory Disease Vaccine Value Chain Analysis
       4.2. Respiratory Disease Vaccine Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Respiratory Disease Vaccine Raw Material Manufactures List
           4.2.3. Price Trend of Respiratory Disease Vaccine Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Respiratory Disease Vaccine Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Respiratory Disease Vaccine Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Respiratory Disease Vaccine Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Respiratory Disease Vaccine Market

6 . GLOBAL RESPIRATORY DISEASE VACCINE MARKET ANALYSIS BY DISEASE TYPE
       6.1 Overview by Disease Type
       6.2 Global Respiratory Disease Vaccine Market Analysis by Disease Type
       6.3 Market Analysis of Chronic Obstructive Pulmonary Disease (COPD) by Regions
       6.4 Market Analysis of Diphtheria by Regions
       6.6 Market Analysis of Measles by Regions
       6.5 Market Analysis of Pertussis by Regions
       6.7 Market Analysis of Pneumonia by Regions

7 . GLOBAL RESPIRATORY DISEASE VACCINE MARKET ANALYSIS BY VACCINE
       7.1 Overview by Vaccine
       7.2 Global Respiratory Disease Vaccine Market Analysis by Vaccine
       7.3 Market Analysis of DTaP by Regions
       7.4 Market Analysis of Haemophilus Influenzae Type B (HIB) by Regions
       7.5 Market Analysis of MMR by Regions
       7.6 Market Analysis of PPSV23 by Regions
       7.7 Market Analysis of Respiratory Syncytial Virus (RSV) by Regions

8 . GLOBAL RESPIRATORY DISEASE VACCINE MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview
           8.3.2. North America Respiratory Disease Vaccine Market Estimate by Market Segment
           8.3.3. North America Respiratory Disease Vaccine Market Estimate by Country
           8.3.4. United State
           8.3.5. Rest of North America
       8.4. Europe
           8.4.1. Overview
           8.4.2. Europe Respiratory Disease Vaccine Market Estimate by Market Segment
           8.4.3. Europe Respiratory Disease Vaccine Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.8 Rest of Europe
       8.5. Asia Pacific
           8.5.1. Overview
           8.5.2. Asia Pacific Respiratory Disease Vaccine Market Estimate by Market Segment
           8.5.3. Asia Pacific Respiratory Disease Vaccine Market Estimate by Country
           8.5.4. China
           8.5.5. Japan
           8.5.6. India
           8.5.8. Rest of Asia Pacific
       8.6. Latin America
           8.6.1. Overview
           8.6.2. Latin America Respiratory Disease Vaccine Market Estimate by Market Segment
           8.6.3. Latin America Respiratory Disease Vaccine Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Rest of Latin America
       8.8. Middle East & Africa
           8.8.1. Overview
           8.8.2. Middle East & Africa Respiratory Disease Vaccine Market Estimate by Market Segment
           8.8.3. Middle East & Africa Respiratory Disease Vaccine Market Estimate by Country
           8.8.4. Middle East
           8.8.5. Africa

9 . COMPETITIVE LANDSCAPE OF THE RESPIRATORY DISEASE VACCINE COMPANIES
       9.1. Respiratory Disease Vaccine Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments

10 . COMPANY PROFILES OF RESPIRATORY DISEASE VACCINE INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. GlaxoSmithKline plc
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Merck & Co., Inc.
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Pfizer Inc.
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Sanofi S.A.
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Serum Institute of India Private Limited
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

Research Scope of Respiratory Disease Vaccine Report
Market Research Process
Market Research Methodology
Global Respiratory Disease Vaccine Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Disease Type
Market Attractiveness Analysis by Vaccine
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Respiratory Disease Vaccine Market Analysis by Disease Type (USD MN)
Global Respiratory Disease Vaccine Market Analysis in Chronic Obstructive Pulmonary Disease (COPD) by Geography (USD MN)
Global Respiratory Disease Vaccine Market Analysis in Diphtheria by Geography (USD MN)
Global Respiratory Disease Vaccine Market Analysis in Measles by Geography (USD MN)
Global Respiratory Disease Vaccine Market Analysis in Pertussis by Geography (USD MN)
Global Respiratory Disease Vaccine Market Analysis in Pneumonia by Geography (USD MN)
Global Respiratory Disease Vaccine Market Analysis by Vaccine (USD MN)
Global Respiratory Disease Vaccine Market Analysis in DTaP by Geography (USD MN)
Global Respiratory Disease Vaccine Market Analysis in Haemophilus Influenzae Type B (HIB) by Geography (USD MN)
Global Respiratory Disease Vaccine Market Analysis in MMR by Geography (USD MN)
Global Respiratory Disease Vaccine Market Analysis in PPSV23 by Geography (USD MN)
Global Respiratory Disease Vaccine Market Analysis in Respiratory Syncytial Virus (RSV) by Geography (USD MN)
Latin America Respiratory Disease Vaccine Market by Revenue
Middle East & Africa Respiratory Disease Vaccine Market by Revenue
Recent Development in Respiratory Disease Vaccine Industry
Company Market Share Analysis

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "